HIMS Hims Hers Health Inc
Company Analysis
Latest News
🔴 Hims Hers Health is trading 7.24% down in pre-market after GAAP loss misses expectations
Hims Hers Health is trading 7.24% down at $29.47 after its August 10, 2026 earnings release, as a GAAP loss of $0.37 per share missed the expected $0.05...
🔴 Hims Hers Health is trading 4.5% down in after-hours trading after a $0.37-per-share loss and margin contraction
Hims Hers Health is trading 4.53% down now at $30.33 after its second-quarter 2026 earnings release, with a $0.37-per-share loss and weaker margins driving the...
Hims & Hers beat second quarter revenue estimates but earnings missed amid margin contraction
Hims & Hers Health reported second quarter 2026 revenue of $753.2 million, exceeding consensus estimates by approximately 8%. However, the company posted a...
Hims Hers Health Inc Q2 2026 Earnings Preview: What Analysts Expect on August 10, 2026
Analyst consensus expects Q2 2026 revenue of $698.9 million and an EPS loss of $0.07, with the current stock price of $31.59 trending above the average analyst...
🟢 Hims Hers Health is trading 5% up today after rebounding from FTC lawsuit losses
Hims Hers Health is trading 5.46% up now at $31.32 after rebounding from losses tied to the FTC lawsuit. • The FTC alleges privacy violations, deceptive...
🟢 Hims Hers Health is trading 5.8% up today after rebounding from FTC lawsuit losses
Hims Hers Health is trading 5.8% up at $31.39 after rebounding from losses tied to the Federal Trade Commission lawsuit. - The FTC alleged privacy violations,...
Hims & Hers Bounces Back From FTC Shock — But Can a Company Built on Trust Survive a Privacy Scandal?
Shares shifted sharply upward as Hims & Hers Health clawed back losses from last week's FTC lawsuit, trading at $29.58 — up 6.5% — and extending a rally that...
🔴 Hims Hers Health is trading 4% down today as no clear company-specific catalyst emerges
Hims Hers Health is trading 4.01% down at $30.38 after no clear company-specific catalyst was identified for the August 6, 2026 decline. - The company...
🟢 Hims Hers Health is trading 4% up today as the rebound from the FTC health data privacy selloff continues
Hims Hers Health is trading 4% up at $32.06 as investors extend a rebound from the recent selloff triggered by an FTC health data privacy complaint. - The...
🟢 Hims Hers Health is trading 10.4% up today as investors buy the dip after FTC-driven selloff
Hims Hers Health is trading 10.4% up at $30.65 as investors continue to buy the dip following last week’s sharp selloff triggered by an FTC health data privacy...
🟢 Hims Hers Health is trading 6.5% up today as shares rebound from an FTC-driven selloff
Hims Hers Health is trading 6.5% up at $29.58 as shares rebound from last week’s sharp decline linked to an FTC health data privacy lawsuit. • Investors are...
Hims & Hers faces investor probe, following FTC health data lawsuit
The U.S. Federal Trade Commission (FTC) sued Hims & Hers on July 29, 2026, for allegedly sharing sensitive consumer health information with Meta and Snap. The...
🟢 Hims Hers Health is trading 5.2% up today as investors buy the dip following FTC lawsuit
• Hims Hers Health is trading 5.2% up at $28.45 as investors buy the recent dip. • The rebound follows a multi-day pullback, largely triggered by a Federal...
🟢 Hims Hers Health is trading 4.6% up today as investors buy the dip amid a broader market rebound
Hims Hers Health is trading at $26.14 (up 4.6%) as investors buy the recent dip following a sharp multi-day pullback earlier this week. • The move appears...
🔴 Hims Hers Health is trading 11.9% down today as profit-taking extends after July rally
Hims Hers Health is trading 11.9% down at $25.84 as investors extend a recent bout of profit-taking following a sharp rally earlier in July. • The stock's...
🔴 Hims Hers Health is trading 6.9% down today amid profit-taking after recent gains
Hims Hers Health is trading 6.9% down at $28.19 as investors lock in profits following a significant recent rally. • The decline follows a sharp run-up in...
🟢 Hims Hers Health is trading 5.3% up
Hims Hers Health is trading at $29.57, up 5.3% from a comparison close of $28.09 during regular trading. This is a price-action follow-up, so a separate...
Hims Stock Whipsaws 10% as FDA Peptide Vote Lands Mid-Selloff — Can the Telehealth Giant Turn Regulatory Relief Into Real Revenue?
Shares of Hims & Hers Health plunged as much as 10.7% to $29.23 on July 24 as traders locked in profits from a sharp multi-week rally and braced for the...
🔴 Hims Hers Health is trading 10.7% down today on profit-taking and FDA peptide meeting caution
Hims Hers Health is trading 10.7% down at $29.23 as traders lock in gains after a sharp multi-week rally and position cautiously ahead of upcoming regulatory...
🔴 Hims Hers Health is trading 4.4% down today on profit-taking and caution ahead of FDA peptide meeting
Hims Hers Health is trading 4.4% down at $31.30 as investors lock in gains following a strong recent rally and ahead of a pivotal regulatory event. • The...